Share this:
New cancer clinical trial: Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer
Published on: December 18, 2020 at 12:00PM
Conditions: Stage IIA Triple Negative Breast Cancer; Triple Negative Breast Cancer
Interventions: Biological: α-lactalbumin vaccine; Biological: Zymosan
Sponsor: George T. Budd
Not yet recruiting
https://ift.tt/2WxD1jG
More Stories
New cancer clinical trial: Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
New cancer clinical trial: Onco-liq: Kit for Breast Cancer Diagnosis.
New cancer clinical trial: PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I